V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20162356 | 20062729 | 1.76 | 77 | Palliative (P) | null | 2017-12-02 | ECX | null | N | ECX | 101358993 |
| 20162359 | 20062730 | 1.8 | 93.7 | Adjuvant (A) | 2017-04-14 | 2017-04-18 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101198671 |
| 20162363 | 20062731 | 1.59 | 65.2 | Neo-adjuvant (N) | 2019-01-27 | 2019-02-10 | ECX | 02 | Y | ECX | 101289679 |
| 20162364 | 20062732 | 1.97 | 92 | Palliative (P) | 2018-02-01 | 2018-02-01 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101717964 |
| 20162381 | 20062733 | 1.59 | 95 | Neo-adjuvant (N) | 2016-07-13 | 2016-07-13 | ECX | N | Y | ECX | 101372983 |
| 20162383 | 20062734 | 1.79 | 75 | Adjuvant (A) | 2017-05-13 | 2017-05-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101450307 |
| 20162384 | 20062735 | 1.72 | 90.6 | Curative (C) | 2017-07-25 | 2017-08-17 | ECX | 02 | null | ECX | 100050639 |
| 20162387 | 20062736 | 1.54 | 76 | Palliative (P) | 2016-09-26 | 2016-10-20 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 100286040 |
| 20162390 | 20062737 | 1.72 | 72.7 | Palliative (P) | 2018-02-12 | 2018-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101357744 |
| 20162395 | 20062738 | 1.6 | 73.4 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-12 | ECX | 2 | N | ECX | 101240603 |
| 20162398 | 20062739 | null | 66.6 | Palliative (P) | 2019-06-04 | 2019-06-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100367273 |
| 20162399 | 20062740 | 1.68 | 59.8 | Curative (C) | 2019-07-17 | 2019-07-25 | ECX | N | Y | ECX | 100414282 |
| 20162407 | 20062741 | null | null | Palliative (P) | 2018-08-06 | 2018-08-06 | Gemcitabine + Capecitabine | N | N | ECX | 100832117 |
| 20162408 | 20062742 | 1.76 | 58.6 | Adjuvant (A) | 2017-12-03 | 2017-12-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100939172 |
| 20162416 | 20062743 | 1.67 | 78 | Curative (C) | 2018-10-14 | 2018-10-28 | ECX | N | N | ECX | 100613533 |
| 20162417 | 20062744 | 1.8 | 76.1 | Palliative (P) | 2020-01-06 | 2020-01-21 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101664842 |
| 20162432 | 20062745 | 1.79 | 68.2 | Palliative (P) | 2017-05-10 | 2017-05-17 | ECX | 02 | N | ECX | 100989013 |
| 20162433 | 20062746 | 1.67 | 65.9 | Palliative (P) | 2018-08-29 | 2018-09-13 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100993175 |
| 20162435 | 20062747 | 1.56 | 47.6 | Adjuvant (A) | null | 2016-12-09 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100182323 |
| 20162446 | 20062748 | 1.71 | 68.2 | Adjuvant (A) | 2018-03-16 | 2018-03-30 | ECX | N | N | ECX | 100048765 |
| 20162447 | 20062749 | 1.67 | 93.3 | Palliative (P) | 2016-11-27 | 2016-12-02 | ECX | N | N | ECX | 101566996 |
| 20162455 | 20062750 | null | null | Palliative (P) | 2018-11-20 | 2018-12-02 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100870237 |
| 20162460 | 20062751 | 1.54 | 77 | Neo-adjuvant (N) | 2018-09-15 | 2018-09-26 | ECX | N | N | ECX | 101248861 |
| 20162462 | 20062752 | 1.61 | 117.8 | Neo-adjuvant (N) | 2016-07-06 | 2016-08-02 | ECX | N | null | ECX | 100953750 |
| 20162466 | 20062753 | 1.71 | 83.4 | Adjuvant (A) | 2017-07-07 | 2017-07-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100663563 |
| 20162468 | 20062754 | 1.75 | 60.9 | Neo-adjuvant (N) | 2019-03-22 | 2019-03-22 | ECX | 2 | N | ECX | 100747983 |
| 20162469 | 20062755 | 1.63 | 76.2 | Palliative (P) | 2016-04-13 | 2016-04-13 | CAPECITABINE + GEMCITABINE | 02 | null | CAPECITABINE + GEMCITABINE | 100841507 |
| 20162472 | 20062756 | 1.74 | 73.2 | Neo-adjuvant (N) | 2018-01-20 | 2018-01-20 | ECX | 2 | N | ECX | 100950571 |
| 20162481 | 20062757 | 1.79 | 59.8 | Neo-adjuvant (N) | 2018-01-08 | 2018-01-19 | ECX | N | N | ECX | 100885796 |
| 20162485 | 20062758 | 1.45 | 90.5 | Neo-adjuvant (N) | 2017-05-20 | 2017-05-28 | ECX | N | null | ECX | 100854865 |
| 20162498 | 20062759 | 1.72 | 72.7 | Palliative (P) | 2016-04-22 | 2016-05-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101702323 |
| 20162507 | 20062760 | 1.63 | 51.7 | Adjuvant (A) | 2019-08-30 | 2019-09-08 | CAPECITABINE + GEMCITABINE | N | N | CAPECITABINE + GEMCITABINE | 100692444 |
| 20162508 | 20062761 | 1.72 | 66.9 | Palliative (P) | 2016-10-02 | 2016-11-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100881010 |
| 20162510 | 20062762 | 1.75 | 72.2 | Palliative (P) | 2017-12-26 | 2018-01-02 | ECX | N | N | ECX | 100409922 |
| 20162512 | 20062763 | 1.6 | 68.2 | Adjuvant (A) | 2017-11-08 | 2017-11-20 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100742351 |
| 20162527 | 20062764 | 1.58 | 62.6 | Adjuvant (A) | 2017-10-02 | 2017-10-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101075282 |
| 20162540 | 20062765 | 1.6 | 80 | Neo-adjuvant (N) | 2019-11-02 | 2019-11-02 | ECX | 02 | N | ECX | 100950015 |
| 20162546 | 20062766 | 1.71 | 72 | Palliative (P) | 2016-12-29 | 2017-01-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100766763 |
| 20162547 | 20062767 | 1.68 | 82 | Adjuvant (A) | null | 2018-09-04 | Gemcitabine + Capecitabine | 01 | N | CAPECITABINE + GEMCITABINE | 101091070 |
| 20162549 | 20062768 | 1.71 | 69.1 | Palliative (P) | 2019-06-01 | 2019-06-15 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101477149 |
| 20162555 | 20062769 | 1.73 | 72.8 | Neo-adjuvant (N) | 2018-12-02 | 2018-12-28 | ECX | 02 | N | ECX | 100585328 |
| 20162558 | 20062770 | 1.66 | 93 | null | 2018-06-24 | 2018-07-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100050868 |
| 20162559 | 20062771 | 1.76 | 56.8 | Neo-adjuvant (N) | 2018-03-02 | 2018-03-11 | ECX | N | N | ECX | 100570062 |
| 20162560 | 20062772 | null | null | Adjuvant (A) | 2016-07-03 | 2016-07-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101379868 |
| 20162561 | 20062773 | 1.56 | 79.75 | Neo-adjuvant (N) | 2019-10-14 | 2019-10-19 | ECX | N | N | ECX | 100107991 |
| 20162566 | 20062774 | 1.53 | 66.7 | Palliative (P) | 2019-01-23 | 2019-02-01 | ECX | 02 | N | ECX | 101141515 |
| 20162571 | 20062775 | 1.81 | 55.2 | Neo-adjuvant (N) | 2017-10-02 | 2017-10-23 | ECX | 02 | N | ECX | 101277410 |
| 20162575 | 20062776 | 1.77 | 69 | Neo-adjuvant (N) | 2018-05-13 | 2018-05-27 | ECX | N | N | ECX | 101266049 |
| 20162578 | 20062777 | 1.72 | 82.45 | Adjuvant (A) | 2017-04-12 | 2017-04-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101654273 |
| 20162584 | 20062778 | 1.78 | 93.5 | Palliative (P) | 2020-03-03 | 2020-03-16 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100692501 |